Company Filing History:
Years Active: 2009-2012
Title: Cornelia Dähnrich: Innovator in Medical Diagnostics
Introduction
Cornelia Dähnrich is a prominent inventor based in Gross Grönau, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the detection and treatment of autoimmune diseases. With a total of 2 patents, her work has the potential to impact the lives of many patients suffering from conditions such as celiac disease and lupus.
Latest Patents
Dähnrich's latest patents include a method and immunoabsorbents for the specific detection and absorption of antibodies associated with celiac disease and dermatitis herpetiformis. This invention relates to fusion peptides derived from components of gliadin, along with methods and reagents for serological diagnosis. Additionally, she has developed a method for producing a nucleosome preparation for in vitro diagnosis of disseminated lupus erythematosus (DLE). This patent focuses on compositions and methods for decreasing blood glucose levels in animals, improving insulin sensitivity, and preventing metabolic conditions such as diabetes and obesity.
Career Highlights
Cornelia Dähnrich is associated with Euroimmun Medizinische Labordiagnostika AG, a company known for its innovative approaches in laboratory diagnostics. Her work at Euroimmun has allowed her to collaborate with leading experts in the field, further enhancing her contributions to medical science.
Collaborations
Some of her notable coworkers include Wolfgang Schlumberger and Winfried Stöcker. Their collaborative efforts have played a crucial role in advancing research and development in medical diagnostics.
Conclusion
Cornelia Dähnrich's innovative work in the field of medical diagnostics exemplifies the impact of dedicated inventors on healthcare. Her patents not only advance scientific knowledge but also offer new hope for patients with autoimmune diseases.